261 related articles for article (PubMed ID: 16805087)
1. Role of CD4+ T cells in a protective immune response against Cryptococcus neoformans in the central nervous system.
Uicker WC; McCracken JP; Buchanan KL
Med Mycol; 2006 Feb; 44(1):1-11. PubMed ID: 16805087
[TBL] [Abstract][Full Text] [Related]
2. Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans.
Uicker WC; Doyle HA; McCracken JP; Langlois M; Buchanan KL
Med Mycol; 2005 Feb; 43(1):27-38. PubMed ID: 15712606
[TBL] [Abstract][Full Text] [Related]
3. CD4
Neal LM; Xing E; Xu J; Kolbe JL; Osterholzer JJ; Segal BM; Williamson PR; Olszewski MA
mBio; 2017 Nov; 8(6):. PubMed ID: 29162707
[No Abstract] [Full Text] [Related]
4. Requirement for CD4(+) T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice.
Buchanan KL; Doyle HA
Infect Immun; 2000 Feb; 68(2):456-62. PubMed ID: 10639404
[TBL] [Abstract][Full Text] [Related]
5. MHC class II-positive perivascular microglial cells mediate resistance to Cryptococcus neoformans brain infection.
Aguirre K; Miller S
Glia; 2002 Aug; 39(2):184-8. PubMed ID: 12112369
[TBL] [Abstract][Full Text] [Related]
6. Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis.
Maffei CM; Mirels LF; Sobel RA; Clemons KV; Stevens DA
Infect Immun; 2004 Apr; 72(4):2338-49. PubMed ID: 15039359
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcus neoformans meningitis in the rat.
Goldman DL; Casadevall A; Cho Y; Lee SC
Lab Invest; 1996 Dec; 75(6):759-70. PubMed ID: 8973471
[TBL] [Abstract][Full Text] [Related]
8. CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans.
Hill JO; Aguirre KM
J Immunol; 1994 Mar; 152(5):2344-50. PubMed ID: 7907637
[TBL] [Abstract][Full Text] [Related]
9. The F-Box Protein Fbp1 Shapes the Immunogenic Potential of
Masso-Silva J; Espinosa V; Liu TB; Wang Y; Xue C; Rivera A
mBio; 2018 Jan; 9(1):. PubMed ID: 29317510
[No Abstract] [Full Text] [Related]
10. Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection.
Lindell DM; Moore TA; McDonald RA; Toews GB; Huffnagle GB
J Immunol; 2005 Jun; 174(12):7920-8. PubMed ID: 15944298
[TBL] [Abstract][Full Text] [Related]
11. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
[TBL] [Abstract][Full Text] [Related]
12. Diversity of the T-cell response to pulmonary Cryptococcus neoformans infection.
Lindell DM; Ballinger MN; McDonald RA; Toews GB; Huffnagle GB
Infect Immun; 2006 Aug; 74(8):4538-48. PubMed ID: 16861640
[TBL] [Abstract][Full Text] [Related]
13. Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells.
Siddiqui AA; Shattock RJ; Harrison TS
Infect Immun; 2006 Sep; 74(9):5302-10. PubMed ID: 16926424
[TBL] [Abstract][Full Text] [Related]
14. Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection.
Garro AP; Chiapello LS; Baronetti JL; Masih DT
Immunology; 2011 Oct; 134(2):198-213. PubMed ID: 21896014
[TBL] [Abstract][Full Text] [Related]
15. Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans.
Mody CH; Lipscomb MF; Street NE; Toews GB
J Immunol; 1990 Feb; 144(4):1472-7. PubMed ID: 1968080
[TBL] [Abstract][Full Text] [Related]
16. Differing requirement for inducible nitric oxide synthase activity in clearance of primary and secondary Cryptococcus neoformans infection.
Aguirre KM; Gibson GW
Med Mycol; 2000 Oct; 38(5):343-53. PubMed ID: 11092381
[TBL] [Abstract][Full Text] [Related]
17. Resistance to Cryptococcus neoformans infection in the absence of CD4+ T cells.
Aguirre K; Crowe J; Haas A; Smith J
Med Mycol; 2004 Feb; 42(1):15-25. PubMed ID: 14982110
[TBL] [Abstract][Full Text] [Related]
18. T11TS immunotherapy augments microglial and lymphocyte protective immune responses against Cryptococcus neoformans in the brain.
Hazra I; Sk Md OF; Datta A; Mondal S; Moitra S; Singh MK; Chaudhuri S; Das PK; Basu AK; Dhar I; Basu N; Chaudhuri S
Scand J Immunol; 2019 Feb; 89(2):e12733. PubMed ID: 30450625
[TBL] [Abstract][Full Text] [Related]
19. The Early Innate Immune Response to, and Phagocyte-Dependent Entry of, Cryptococcus neoformans Map to the Perivascular Space of Cortical Post-Capillary Venules in Neurocryptococcosis.
Kaufman-Francis K; Djordjevic JT; Juillard PG; Lev S; Desmarini D; Grau GER; Sorrell TC
Am J Pathol; 2018 Jul; 188(7):1653-1665. PubMed ID: 29929915
[TBL] [Abstract][Full Text] [Related]
20. IL-25 Receptor Signaling Modulates Host Defense against
Hansakon A; Jeerawattanawart S; Pattanapanyasat K; Angkasekwinai P
J Immunol; 2020 Aug; 205(3):674-685. PubMed ID: 32561567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
